Cardiorenal protection in focus – using modern therapy options

Type 2 diabetics can lead a relatively normal life if they adhere to therapy guidelines and maintain _HbA1c levels for as many years as possible.
are in the target area. Conversely, derailed glycemic control over time increases the risk of microvascular and macrovascular complications. In the pathogenesis of diabetic nephropathy are included
In addition to metabolic, hemodynamic and inflammatory factors are also involved. In addition to SGLT-2-i and GLP-1-RA, finerenone may also slow the progression of chronic kidney disease and reduce the risk of cardiovascular events.